Format

Send to

Choose Destination
Endocr Connect. 2018 Apr;7(4):504-510. doi: 10.1530/EC-18-0082. Epub 2018 Mar 12.

Clinical diagnosis of Graves' or non-Graves' hyperthyroidism compared to TSH receptor antibody test.

Author information

1
Faculty of BiologyMedicine and Health, University of Manchester, Manchester, UK.
2
Endocrinology & DiabetesSalford Royal NHS Foundation Trust, Salford, UK.
3
Faculty of BiologyMedicine and Health, University of Manchester, Manchester, UK louise.hunter@manchester.ac.uk.
4
CEDM Centre of EndocrinologyDiabetes & Metabolism, Limassol, Cyprus.

Abstract

BACKGROUND:

TSH receptor antibody (TRAb) is considered the gold standard diagnostic test for the autoimmunity of Graves' disease (GD), which is commonly diagnosed clinically.

AIM:

To evaluate the true positive (sensitivity) and true negative (specificity) rates of clinical diagnosis of GD or non-GD hyperthyroidism compared to the TRAb test.

SETTING:

University teaching hospital in North West England.

PARTICIPANTS:

Patients in the Endocrinology service who had a TRAb measurement between December 2009 and October 2015.

METHODS:

Electronic patient records were studied retrospectively for a pre-TRAb clinical diagnosis of GD or non-GD hyperthyroidism. We examined descriptive statistics and binary classification tests; Fisher exact test was used to analyse contingency tables.

RESULTS:

We identified 316 patients with a mean age of 45 (range, 17-89) years; 247 (78%) were women. Compared to the TRAb result, clinical diagnosis had a sensitivity of 88%, specificity 66%, positive predictive value 72%, negative predictive value 84%, false negative rate 12%, false positive rate 34%, positive likelihood ratio 2.6 and negative likelihood ratio 0.2 (P < 0.0001).

CONCLUSIONS:

Clinicians were liable to both over- and under-diagnose GD. The TRAb test can help reduce the number of incorrect or unknown diagnoses in the initial clinical assessment of patients presenting with hyperthyroidism.

KEYWORDS:

Graves’ disease; hyperthyroidism; sensitivity; specificity; thyroid-stimulating immunoglobulins

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center